Intrinsic Value of S&P & Nasdaq Contact Us

Marcus & Millichap, Inc. MMI NYSE

NYSE • Real Estate • Real Estate - Services • US • USD

SharesGrow Score
37/100
0/7 Pass
SharesGrow Intrinsic Value
$3.20
-88.1%
Analyst Price Target
$26.00
-3.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Marcus & Millichap, Inc. (MMI) has a negative trailing P/E of -538.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 55.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -0.19%, forward earnings yield 1.81%. PEG 0.67 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (35/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -538.2); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -0.19%).
  • Forward P/E 55.1 — analysts expect a return to profitability with estimated EPS of $0.49 for FY2026.
  • PEG Ratio 0.67 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -0.19% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 1.81% as earnings recover.
  • Analyst consensus target $26.00 (-3.8% downside) — slight downside risk — the market may be ahead of analyst expectations.

Overall SharesGrow Score: 37/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
37/100
SG Score
View full scorecard →
VALUE
35/100
Price-to-Earnings & upside
Proven by this page
FUTURE
26/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
56/100
→ Income
~
GROWTH
40/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — MMI

Valuation Multiples
P/E (TTM)-538.2
Forward P/E55.1
PEG Ratio0.67
Forward PEG0.67
P/B Ratio1.70
P/S Ratio1.34
EV/EBITDA58.4
Per Share Data
EPS (TTM)$-0.05
Forward EPS (Est.)$0.49
Book Value / Share$15.53
Revenue / Share$19.45
FCF / Share$1.51
Yields & Fair Value
Earnings Yield-0.19%
Forward Earnings Yield1.81%
Dividend Yield1.89%
SharesGrow IV$3.20 (-88.1%)
Analyst Target$26.00 (-3.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 16.1 -5.50 4.02 1.45 -
2017 24.7 -1.20 4.04 1.77 -
2018 15.4 0.22 3.28 1.65 -
2019 19.1 -1.52 2.97 1.82 -
2020 34.5 -0.77 2.70 2.06 -
2021 14.4 0.06 2.95 1.58 -
2022 13.2 -0.49 1.93 1.06 4.39%
2023 -49.6 0.37 2.62 2.61 1.19%
2024 -119.7 1.88 2.35 2.13 1.37%
2025 -556.7 6.57 1.76 1.41 1.93%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $1.66 $717.45M $64.66M 9%
2017 $1.32 $719.7M $51.52M 7.2%
2018 $2.22 $814.82M $87.26M 10.7%
2019 $1.95 $806.43M $76.93M 9.5%
2020 $1.08 $716.91M $42.84M 6%
2021 $3.55 $1.3B $142.47M 11%
2022 $2.59 $1.3B $104.23M 8%
2023 $-0.88 $645.93M $-34.04M -5.3%
2024 $-0.32 $696.06M $-12.36M -1.8%
2025 $-0.05 $755.16M $-1.91M -0.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.49 $0.46 – $0.52 $852.65M $820.5M – $884.8M 1
2027 $0.89 $0.83 – $0.95 $949.4M $890.8M – $1.01B 1
2028 $1.63 $1.52 – $1.74 $1.14B $1.09B – $1.2B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message